CHLORAPREP ONE-STEP Drug Patent Profile
✉ Email this page to a colleague
When do Chloraprep One-step patents expire, and when can generic versions of Chloraprep One-step launch?
Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. There is one patent protecting this drug.
This drug has twelve patent family members in eleven countries.
The generic ingredient in CHLORAPREP ONE-STEP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
DrugPatentWatch® Generic Entry Outlook for Chloraprep One-step
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORAPREP ONE-STEP?
- What are the global sales for CHLORAPREP ONE-STEP?
- What is Average Wholesale Price for CHLORAPREP ONE-STEP?
Summary for CHLORAPREP ONE-STEP
| International Patents: | 12 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 45 |
| What excipients (inactive ingredients) are in CHLORAPREP ONE-STEP? | CHLORAPREP ONE-STEP excipients list |
| DailyMed Link: | CHLORAPREP ONE-STEP at DailyMed |
Recent Clinical Trials for CHLORAPREP ONE-STEP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yaneve Fonge | Phase 4 |
| Rush University Medical Center | N/A |
| Gebauer Company | Phase 4 |
Pharmacology for CHLORAPREP ONE-STEP
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for CHLORAPREP ONE-STEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-001 | Jul 14, 2000 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-008 | Oct 23, 2008 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-004 | Aug 20, 2003 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORAPREP ONE-STEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-001 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-001 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
| Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-001 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CHLORAPREP ONE-STEP
See the table below for patents covering CHLORAPREP ONE-STEP around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
